Home
Notification
Profile
Trending Articles
News
Bookmarked and Liked
History
Creator Center
Settings
币界网
--
Follow
Coin World News, according to Bitget market data, BIO has fallen nearly 37.5% from its recent high of 0.32 USDT, currently reported at 0.2 USDT, with a 24-hour decline of 16.82%.
#USDT
Disclaimer: Includes third-party opinions. No financial advice. May include sponsored content.
See T&Cs.
BIO
0.1856
-8.43%
442
0
Explore the latest crypto news
⚡️ Be a part of the latests discussions in crypto
💬 Interact with your favorite creators
👍 Enjoy content that interests you
Email / Phone number
Sign Up
Login
Relevant Creator
币界网
@BiJieWang
Follow
Explore More From Creator
币界网消息,CME“美联储观察”显示,美联储9月维持利率不变的概率为12.2%,降息25个基点的概率为87.8%。此外,10月维持利率不变的概率为6.2%,累计降息25个基点的概率为50.6%,累计降息50个基点的概率为43.2%。
--
币界网消息,8 月 27 日(UTC+8),据 Bitget 行情数据显示,HYPE 现报价 49.57 美元, 24小时涨幅达 15%。
--
币界网报道,芝商所(CME)宣布,其加密货币期货的名义未平仓合约首次突破300亿美元,其中SOL和XRP期货的名义未平仓合约均突破10亿美元。XRP成为最快达到这一里程碑的合约,仅用了三个多月的时间。
--
币界网消息,8 月 27 日(UTC+8),美国财政部长Scott Bessent表示,来自特朗普关税政策的海关税收收入可能每年超过 5000 亿美元,并有望接近 1 万亿美元。他指出,7 月至 8 月关税收入大幅上升,预计 9 月增幅更大。今年共和党通过的减税与支出法案预计将在未来十年增加 3.4 万亿美元赤字,而关税收入被视为抵消部分缺口的重要来源。国会预算办公室最新预测称,特朗普的关税政策可在十年内减少 4 万亿美元赤字,高于此前 3 万亿美元的估算。
--
币界网消息,Kindly MD, Inc. 向美国证券交易委员会提交 S-3 注册声明,拟通过基础招股书及补充文件不定期发行最多 50 亿美元的普通股、优先股、债券、认股权证、购买权和单位等证券。发行所得将用于比特币储备战略、营运资金、债务偿还、并购、资本开支及股票回购等一般企业用途,具体用途由管理层酌情决定。
--
Latest News
Ethereum(ETH) Surpasses 4,600 USDT with a 4.26% Increase in 24 Hours
--
BNB Surpasses 860 USDT with a 0.59% Increase in 24 Hours
--
Bitcoin(BTC) Surpasses 111,000 USDT with a Narrowed 0.76% Decrease in 24 Hours
--
Trump Considers New Appointment for Federal Reserve Board
--
U.S. Commerce Department to Release Statistics on Blockchain
--
View More
Trending Articles
XRP Holders Alert: “It’s Over, Prepare Now,” Warns Market Strategist Levi Rietveld
news btc698
Invisible trap:
Nena Rousu zQF8
Alt Coins & BTC Are Ready To Crash
MU_Traders
China to Commission Aircraft Carrier Fujian (Type 003), Boos
Ripam
$SOL 🔥 SOL/USDT Overview @ 194.14 Trend
MR CRYPTO LOVER
View More
Sitemap
Cookie Preferences
Platform T&Cs